Buy Balchem

Logo for stock BCPC (Balchem)

Amount

£
GBP

Latest price

$166.50
(£1.00 = $1.295)

Number of shares (est.)

0

Start investing today

Open an investment account in Emma and enjoy commission free stock trading. Capital at risk, other charges apply.

QR code linking to downloads for the Emma app.
Download on the App Store buttonGet it on Google Play button

Metrics

Market Cap

$5.417B

P/E ratio

42.40

EPS

$3.927

Beta

0.75

Dividend rate

$0.87

Dividend yield

0.52%

About

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

CEO

Mr. Theodore L. (Ted) Harris

Employees

1,361

Sector

Consumer Goods

Company HQ

MONTVALE, United States of America

News

Logo for news article #0 (Balchem Corporation to Participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025)

Balchem Corporation to Participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025

MONTVALE, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025.

GlobeNewsWire

February 25, 2025

Logo for news article #1 (Balchem Is A Great Company, But I'm Still Waiting For A Better Entry)

Balchem Is A Great Company, But I'm Still Waiting For A Better Entry

Balchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw modest revenue growth of 4.9%, with notable gains in GAAP earnings (23.8%) and adjusted EBITDA (13.4%), driven by strong Human Nutrition & Health performance. Despite growth in key segments, Balchem's high valuation and macroeconomic pressures suggest waiting for a more attractive entry point for new investors.

Seeking Alpha

February 24, 2025

Logo for news article #2 (Balchem Corporation (BCPC) Q4 2024 Earnings Conference Call Transcript)

Balchem Corporation (BCPC) Q4 2024 Earnings Conference Call Transcript

Balchem Corporation (NASDAQ:BCPC ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call Participants Bob Labick - CJS Securities Ram Selvaraju - H.C. Wainwright & Co Daniel Harriman - Sidoti & Company Operator Greetings, and welcome to Balchem's Fourth Quarter and Full Year 2024 Earnings Call.

Seeking Alpha

February 21, 2025

Emma logo
Facebook logoTiktok logoTwitter / X logoInstagram logo

© 2025 Emma Technologies Ltd. All Rights Reserved.

Emma is registered and incorporated in England and Wales.

Emma Technologies Ltd is an appointed representative of RiskSave Technologies Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 775330).

Payment services (Non MIFID or Deposit related products) for Emma Technologies Ltd are provided by The Currency Cloud Limited. Registered in England No. 06323311. Registered Office: Stewardship Building 1st Floor, 12 Steward Street London E1 6FQ. The Currency Cloud Limited is authorised by the Financial Conduct Authority under the Electronic Money Regulations 2011 for the issuing of electronic money (FRN: 900199). For more detail on how your money is protected please see here. You can also find Currency Cloud's Terms of Use here.

Emma Technologies Ltd is an Introducer Appointed Representative of Quint Group Limited, which is authorised and regulated by the Financial Conduct Authority (FRN 669450). Emma Technologies Ltd is not a lender. Emma Technologies Ltd introduces customers to Monevo Limited who is a licensed credit broker.

Emma is registered with the Financial Conduct Authority under the Payment Services Regulations 2017 for the provision of payment services.

Financial Conduct Authority Reg Nr: 794952.
Company Registration Number: 10578464.
Data Protection Registration Number: ZA241546.

All testimonials, reviews, opinions or case studies presented on our website may not be indicative of all customers. Results may vary and customers agree to proceed at their own risk.